Stay updated on BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page footer.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedAdded an expanded Locations section with state-specific study sites and updated the revision tag to v3.3.3. Removed the HHS Vulnerability Disclosure link and the prior v3.3.2 entry.SummaryDifference1%

- Check56 days agoChange DetectedThe page shows a new revision label: v3.3.2, replacing the previous v3.2.0. This indicates a minor update to the page version and does not change the study details.SummaryDifference0.0%

- Check63 days agoChange DetectedThe government funding status notice about potential delays and the NIH Clinical Center operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange DetectedNo significant content changes were detected; the two screenshots appear to show the same study details with only minor UI/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check106 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0 tag.SummaryDifference4%

Stay in the know with updates to BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.